trial

Clinical Intervention Psychosis and Addiction

NCTId NCT01411566
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Early Phase 1 · Unknown
Enrollment 122 (estimated)
Sponsored by University of Cologne
Primary completion 2011-11
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Early Phase 1
Status
Unknown
Enrollment
122 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2011-01
Primary completion
2011-11
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
Skills trainig for patients with dual diagnosisregular treatment

Sponsors

University of CologneLead Sponsor

Investigators

1
Joerg Daumann, PhDStudy Chair

Sites

1 total
Cologne, Germany

Facts & assertions

4 sourced
Enrollment
122
Phase
EARLY_PHASE1
Primary Completion Date
2011-11
Status
UNKNOWN
relationships
The graph out of here
drug
Skills trainig for patients with dual diagnosis
drug
regular treatment
drug
lead_sponsor
University of Cologne
company
indication
Psychosis
indication
Substance-Related Disorders
indication
Substance Abuse
indication
investigator
Joerg Daumann, PhD
person